Worth Asset Management, LLC Amgen Inc Transaction History

Worth Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$309.38 - $337.38 $317,733 - $346,489	1,027 New	1,027 $330,000
Q1 2023 Apr 12, 2023	SELL	$225.79 - $275.2 $1,806 - $2,201	-8 Reduced 28.57%	20 $4,000
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $916 - $1,164	-4 Reduced 12.5%	28 $0
Q3 2022 Oct 07, 2022	SELL	$224.46 - $253.15 $1.28 Million - $1.45 Million	-5,715 Reduced 99.44%	32 $8,000
Q2 2022 Jul 08, 2022	BUY	$230.71 - $256.74 $1.22 Million - $1.36 Million	5,289 Added 1154.8%	5,747 $1.4 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $100,425 - $111,097	458 New	458 $112,000

3,119

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Worth Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Asset Management, LLC with notifications on news.